Renowned British actor Patrick Stewart died Wednesday at the age of 86, with his spokesperson confirming Thursday that his death was attributed to a combination of Alzheimer’s disease and Lewy body dementia. The celebrated Shakespearean performer, widely known for his iconic roles as Captain Jean-Luc Picard in the Star Trek franchise and Professor Charles Xavier in the X-Men films, passed away leaving behind a legacy spanning decades of stage and screen work.
Medical experts note that Alzheimer’s and Lewy body dementia frequently co-occur, a combination that can accelerate a patient’s physical and cognitive decline. According to Dr. Keith Vossel, a neurology professor at the University of California, Los Angeles, Lewy body dementia is the second-most-common form of degenerative dementia globally, trailing only Alzheimer’s disease. The condition arises when a protein named alpha-synuclein aggregates into abnormal clumps within the brain. Despite its prevalence, Lewy body dementia remains frequently under-recognized and under-diagnosed, largely because its early symptoms often overlap with those characteristic of Alzheimer’s.
The condition derives its name from Dr. Friedrich H. Lewy, the neurologist who initially identified the characteristic brain abnormalities during the early 20th century, as documented by the Alzheimer’s Association. Vossel explains that definitive diagnosis of these concurrent conditions typically requires a post-mortem examination, where hallmark features can be observed directly under a microscope.
Symptom progression in Lewy body dementia often begins with rapid eye movement sleep behavior disorder, manifesting as physical actions during sleep such as screaming, kicking, or flailing. Patients may subsequently develop physical rigidity or tremors in the limbs, alongside a noticeable slowness of movement. Clinical criteria dictate that a formal diagnosis of Lewy body dementia may be made when cognitive symptoms manifest within one year of these motor changes. Cognitive indicators frequently include vivid illusions or visual hallucinations—with some individuals reporting the sensation of a shadowy figure standing nearby—as well as persistent difficulties with problem-solving and spatial navigation. Furthermore, patients often experience dramatic, rapid fluctuations in alertness and attention occurring within the same day.
Anxiety frequently emerges as an early hallmark of Lewy body dementia, according to Vossel. By contrast, Alzheimer’s disease is traditionally characterized by memory and language impairment, accompanied more frequently by apathy and depression rather than acute anxiety. The trajectory of Alzheimer’s disease also tends to progress at a slightly slower pace than Lewy body dementia.
Demographic risk factors show that Lewy body dementia affects men at higher rates than women. While any individual over the age of 60 faces an elevated risk of developing degenerative neurological conditions, Lewy body dementia most commonly strikes individuals in their 70s and 80s.
Currently, there is no known cure for Lewy body dementia, which is both progressive and terminal. Following diagnosis, individuals typically live for six to eight years before requiring round-the-clock professional care. Nevertheless, targeted medications can assist in managing specific symptoms, and ongoing clinical research indicates that maintaining cardiovascular fitness may help slow the overall rate of cognitive and physical decline.
Health specialists advise that anyone experiencing suspected symptoms of Lewy body dementia should seek a comprehensive evaluation from a neurologist or a clinician specializing in geriatric medicine or geriatric psychiatry.
